§ 13F · FUND PROFILE
Elmind Capital, LP.
AUM · $398M (13F)Positions · 35Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$34M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | COGT | COGENT BIOSCIENCES INC | 1.17M | $45M | 11.4% | ±0% |
| 2 | SNDX | SYNDAX PHARMACEUTICALS INC | 1.85M | $41M | 10.2% | ±0% |
| 3 | CLDX | CELLDEX THERAPEUTICS INC NEW | 990K | $37M | 9.3% | +14% |
| 4 | RLAY | RELAY THERAPEUTICS INC | 1.47M | $27M | 6.9% | +173% |
| 5 | PCVX | VAXCYTE INC | 452K | $26M | 6.6% | +43% |
| 6 | VERA | VERA THERAPEUTICS INC | 437K | $19M | 4.7% | −10% |
| 7 | PHVS | PHARVARIS N V | 526K | $18M | 4.6% | +11% |
| 8 | VRDN | VIRIDIAN THERAPEUTICS INC | 985K | $18M | 4.5% | +84% |
| 9 | CTMX | CYTOMX THERAPEUTICS INC. | 4.55M | $17M | 4.3% | ±0% |
| 10 | TVTX | TRAVERE THERAPEUTICS INC | 293K | $17M | 4.2% | +65% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ELMIND SIGNAL
AC read
Elmind Capital, LP is a Other fund managing $398 million in assets. The fund runs a portfolio of 35 positions.
Read the full dossier →